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Response to “The Biobank Act as a route to
responsible research: A first step for Taiwan?”Regarding to the article written by Dr. Ching-Yi Liu,1 on
behalf of the Department of Health, I would like to make
the following comments. First of all, the amended Biobank
Act on Article 29 and Article 30 has been passed by the
Legislative Yuan and came into effect on January 26, 2011.
Amended Article 29 has already specified that Articles 6,
15, 16, and 20 shall apply, where appropriate, to those
biomedical researches not using the biologic specimens,
derivatives, relevant data, and information from the bio-
bank. In addition, for those genetic analyses that could not
be carried out in Taiwan or due to other special reasons
could be exported under the approval of the Competent
Authority if the biological specimens are not from the bio-
bank. Furthermore, the corrective process has also been
postponed until February 2012 in the amended Article 30 as
well. As for the research area a biobank could serve,
a biobank can serve genetic and nongenetic research that
has been approved by the institutional review board and0929-6646/$ - see front matter Copyright ª 2011, Elsevier Taiwan LLC
doi:10.1016/j.jfma.2011.06.005only if the nongenetic research has already been included
in the informed consent [Article 7(6)].
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